Article Details
Retrieved on: 2021-01-26 09:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's investigational bispecific antibody faricimab has hit the primary endpoint in two Phase III studies in people living with neovascular or wet ...
Article found on: www.pharmatimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here